{"id":15193,"date":"2026-11-18T08:00:00","date_gmt":"2026-11-18T07:00:00","guid":{"rendered":"https:\/\/bict.it\/?p=15193"},"modified":"2026-11-18T08:17:39","modified_gmt":"2026-11-18T07:17:39","slug":"efsa-opinion-solein-xanthobacter","status":"publish","type":"post","link":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/","title":{"rendered":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">On 9 November 2026 the EFSA NDA Panel published its opinion on powdered bacterial biomass of <em>Xanthobacter<\/em> sp. SoF1, the protein ingredient that Solar Foods Oy markets as Solein. The conclusion: the novel food is <strong>safe under the proposed conditions of use<\/strong>, as an ingredient in several food categories for the general population. The next step is the Commission implementing regulation that adds it to the Union list.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What the dossier rested on<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">EFSA considers the information on the production process, composition, stability and specifications sufficient, with no safety concerns. There are no concerns regarding genotoxicity, and the 90-day oral study showed no adverse effects up to the highest dose tested, 1500 mg\/kg body weight per day. At the highest intake estimates, the lowest margin of exposure is 212, in children. The allergenic potential remains unknown, and cross-reactivity with known allergens cannot be excluded.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The timeline shows how much those sections weigh. From the OpenEFSA record: dossier received on 18 February 2022, valid from 1 August 2023, opinion adopted on 31 August 2026. In between, four clock stops with data requests that return again and again to the identity of the novel food, the production process, compositional data and specifications, as well as genotoxicity, toxicity, allergenicity and use levels.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">An in vitro read-out inside a novel food opinion<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">The opinion also relies on a cell model. After in vitro colonic fermentation, proteolytic fermentation produced branched short-chain fatty acids and ammonia, consistent with modest protein quality; on Caco-2 cells the fermented material gave a modest increase in epithelial permeability, with no cytotoxicity and no loss of cell viability. The in vitro data read a local effect on the intestinal epithelium and sit alongside the 90-day study, which remains the basis for the toxicological reference point.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">The contrast with benfotiamine<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">A month earlier, on 9 October, the same Panel concluded that the safety of benfotiamine as a novel food in food supplements cannot be established. The reasons sit in the same sections: identity not sufficiently demonstrated, including small particles and nanoparticles; reproducibility of the manufacturing process not demonstrated; no conclusion on microbiological stability over the shelf life.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What it means for ingredient developers<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">For a fermentation-derived ingredient, the dossier is built before the dossier: a described process, specifications documented batch by batch, analytical methods able to support them, and in vitro intestinal models when a local effect needs to be read. This is the work BiCT does in <a href=\"https:\/\/bict.it\/en\/divisions\/food-supplement\/new-ingredients\/\">new ingredient development<\/a>, from fermentation to analytical methods.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Sources<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>EFSA NDA Panel, Safety of powdered <em>Xanthobacter<\/em> sp. SoF1 biomass as a novel food pursuant to Regulation (EU) 2015\/2283, EFSA Journal, 9 November 2026: <a href=\"https:\/\/doi.org\/10.2903\/j.efsa.2026.10327\">doi.org\/10.2903\/j.efsa.2026.10327<\/a><\/li>\n\n\n\n<li>EFSA NDA Panel, Safety of benfotiamine as a novel food pursuant to Regulation (EU) 2015\/2283, EFSA Journal, 9 October 2026: <a href=\"https:\/\/doi.org\/10.2903\/j.efsa.2026.10301\">doi.org\/10.2903\/j.efsa.2026.10301<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>On 9 November 2026 EFSA concluded that powdered Xanthobacter sp. SoF1 biomass is safe under the proposed conditions of use. The opinion shows what a novel food dossier for a fermentation-derived ingredient rests on.<\/p>\n","protected":false},"author":7,"featured_media":15187,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[95],"tags":[91,105,87,88],"class_list":["post-15193","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-food-supplement-en","tag-fermentation","tag-in-vitro-en","tag-insight","tag-update"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict\" \/>\n<meta property=\"og:description\" content=\"On 9 November 2026 EFSA concluded that powdered Xanthobacter sp. SoF1 biomass is safe under the proposed conditions of use. The opinion shows what a novel food dossier for a fermentation-derived ingredient rests on.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/\" \/>\n<meta property=\"og:site_name\" content=\"Bict\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-18T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-18T07:17:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"elisa-bict\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elisa-bict\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/\"},\"author\":{\"name\":\"elisa-bict\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/person\\\/236f38e7137ba2000813ad139ae10c28\"},\"headline\":\"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model\",\"datePublished\":\"2026-11-18T07:00:00+00:00\",\"dateModified\":\"2026-11-18T07:17:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/\"},\"wordCount\":469,\"publisher\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/news-solein-en-1.jpg\",\"keywords\":[\"Fermentation\",\"In vitro\",\"Insight\",\"Update\"],\"articleSection\":[\"Food Supplement\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/\",\"url\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/\",\"name\":\"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/news-solein-en-1.jpg\",\"datePublished\":\"2026-11-18T07:00:00+00:00\",\"dateModified\":\"2026-11-18T07:17:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/news-solein-en-1.jpg\",\"contentUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/news-solein-en-1.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/efsa-opinion-solein-xanthobacter\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bict.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bict.it\\\/#website\",\"url\":\"https:\\\/\\\/bict.it\\\/\",\"name\":\"Bict\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bict.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\",\"name\":\"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES\",\"url\":\"https:\\\/\\\/bict.it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png\",\"contentUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png\",\"width\":351,\"height\":167,\"caption\":\"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/person\\\/236f38e7137ba2000813ad139ae10c28\",\"name\":\"elisa-bict\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"caption\":\"elisa-bict\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/","og_locale":"en_US","og_type":"article","og_title":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict","og_description":"On 9 November 2026 EFSA concluded that powdered Xanthobacter sp. SoF1 biomass is safe under the proposed conditions of use. The opinion shows what a novel food dossier for a fermentation-derived ingredient rests on.","og_url":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/","og_site_name":"Bict","article_published_time":"2026-11-18T07:00:00+00:00","article_modified_time":"2026-11-18T07:17:39+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg","type":"image\/jpeg"}],"author":"elisa-bict","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elisa-bict","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#article","isPartOf":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/"},"author":{"name":"elisa-bict","@id":"https:\/\/bict.it\/#\/schema\/person\/236f38e7137ba2000813ad139ae10c28"},"headline":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model","datePublished":"2026-11-18T07:00:00+00:00","dateModified":"2026-11-18T07:17:39+00:00","mainEntityOfPage":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/"},"wordCount":469,"publisher":{"@id":"https:\/\/bict.it\/#organization"},"image":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#primaryimage"},"thumbnailUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg","keywords":["Fermentation","In vitro","Insight","Update"],"articleSection":["Food Supplement"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/","url":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/","name":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model - Bict","isPartOf":{"@id":"https:\/\/bict.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#primaryimage"},"image":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#primaryimage"},"thumbnailUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg","datePublished":"2026-11-18T07:00:00+00:00","dateModified":"2026-11-18T07:17:39+00:00","breadcrumb":{"@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#primaryimage","url":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg","contentUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/news-solein-en-1.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/bict.it\/en\/efsa-opinion-solein-xanthobacter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bict.it\/en\/"},{"@type":"ListItem","position":2,"name":"EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro model"}]},{"@type":"WebSite","@id":"https:\/\/bict.it\/#website","url":"https:\/\/bict.it\/","name":"Bict","description":"","publisher":{"@id":"https:\/\/bict.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bict.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bict.it\/#organization","name":"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES","url":"https:\/\/bict.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bict.it\/#\/schema\/logo\/image\/","url":"https:\/\/bict.it\/wp-content\/uploads\/2021\/10\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png","contentUrl":"https:\/\/bict.it\/wp-content\/uploads\/2021\/10\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png","width":351,"height":167,"caption":"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES"},"image":{"@id":"https:\/\/bict.it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/bict.it\/#\/schema\/person\/236f38e7137ba2000813ad139ae10c28","name":"elisa-bict","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","caption":"elisa-bict"}}]}},"_links":{"self":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/15193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/comments?post=15193"}],"version-history":[{"count":2,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/15193\/revisions"}],"predecessor-version":[{"id":15195,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/15193\/revisions\/15195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/media\/15187"}],"wp:attachment":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/media?parent=15193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/categories?post=15193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/tags?post=15193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}